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Systemic sclerosis (SSc) is a connective tissue disorder of unknown ethiology with 
two diff erent subsets: limited (lSSc) and diff use cutaneous systemic sclerosis (dSSc) 
with diff erent patterns of organ involvement, autoantibody profi les and survival 
(1). The disease is characterized by three major features: vascular endothelial injury, 
inﬂ ammation/autoimmunity and massive deposition of collagen. Many extracellu-
lar matrix proteins are altered in SSc, including fi brillin (2). Fibrillin microfi brils form 
anchoring fi laments in lymphatic endothelium. In the wall of arteries they constitute 
a scaff old for elastin deposition and sequester in the matrix TGFb and other mole-
cules which regulate matrix formation and remodeling (3). The aim of this study was 
to evaluate the eff ect of SSc sera on fi brillin and microfi bril associated glycoprotein-1 
(MAGP-1) deposition by human adult dermal blood (BHMVEC) and lymphatic (LyH-
MVEC) microvascular endothelial cells.
Cells were cultured on gelatine-coated coverslips in EBM containing 15% of serum 
of lSSc or dSSc patients, naive or under pharmacological therapy, and of controls and 
fi xed at days 2 and 4 of conﬂ uence. Double immunoﬂ uorescence was performed with 
a monoclonal antibody to fi brillin-1 and a polyclonal antibody to MFPA2. Fibrillin 
and MAGP-1 deposition were quantifi ed on 30 random photographic fi elds/slide.
Fibrillin and MAGP-1 were produced by BHMVEC and LyHMVEC in all experi-
mental conditions. They co-localized forming a honeycomb pattern in BHMVEC, as 
previously described (4), and a dense mesh of short segments in LyHMVEC. Compar-
ative evaluation between LyHMVEC and BHMVEC indicated that, at day 4, LyHM-
VEC produced more fi brillin than BHMVEC in all experimental conditions. In BHM-
VEC, Fibrillin and MAGP-1 production signifi cantly increased with time under chal-
lenge with naive lSSc sera, and with dSSc sera irrespective of therapy, as compared 
with control sera. In LyHMVEC, their production signifi cantly increased with time 
after challenge with both SSc and control sera, without any signifi cant diff erence.
Overall, LyHMVEC produced more but less organized fi brillin and MAGP-1 and 
were less inﬂ uenced by SSc sera than BHMVEC.
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